✦ LIBER ✦

The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder

✍ Scribed by McIntyre, Roger S.; Alsuwaidan, Mohammad; Soczynska, Joanna K.; Szpindel, Isaac; Bilkey, Timothy S.; Almagor, Doron; Woldeyohannes, Hanna O.; Powell, Alissa M.; Cha, Danielle S.; Gallaugher, Laura Ashley; Kennedy, Sidney H.

Book ID: 126638615
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 102 KB
Volume: 28
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.2325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of lisdexamfetamine dimesylate on

Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder

✍ Lenard A Adler; David Goodman; Richard Weisler; Mohamed Hamdani; Thomas Roth 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 380 KB

P.1.i.038 Long-term safety and efficacy

P.1.i.038 Long-term safety and efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

✍ R. Lasser; R. Weisler; J. Young; G. Mattingly; J. Gao; L. Adler; L. Squires 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

P-339 - Effect of lisdexamfetamine dimes

P-339 - Effect of lisdexamfetamine dimesylate on functional impairment in children and adolescents with attention-deficit/hyperactivity disorder

✍ C.A. Soutullo; T. Banaschewski; M.L. Lecendreux; R. Bloomfield; P. Hodgkins; D.R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 106 KB

P03-332 - Effect of treatment with lisde

P03-332 - Effect of treatment with lisdexamfetamine dimesylate on self-reported quality of life in adults with attention-deficit/hyperactivity disorder

✍ J. Giblin; M. Brams; J. Gao; M. Gasior; L. Squires; T. Wigal 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 34 KB

EPA-0682 – Investigator-rated symptomato

EPA-0682 – Investigator-rated symptomatological outcomes in a phase 4 study of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder and impaired executive function

✍ Adler, L.; Raychaudhuri, A.; Dirks, B. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 77 KB

EPA-0672 – Efficacy outcomes in age and

EPA-0672 – Efficacy outcomes in age and sex subgroups from two clinical trials of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder

✍ Adler, L.A.; Dirks, B.; Adeyi, B.; Squires, L.A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 62 KB